Lortab and Light chain analysis increased - a phase IV clinical study of FDA data

Summary:

Light chain analysis increased is reported as a side effect among people who take Lortab (acetaminophen; hydrocodone bitartrate), especially for people who are female, 40-49 old, also take Lasix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Light chain analysis increased when taking Lortab. It is created by eHealthMe based on reports of 29,547 people who have side effects when taking Lortab from the FDA, and is updated regularly.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.

What is Light chain analysis increased?

Light chain analysis increased is found to be associated with 198 drugs and 149 conditions by eHealthMe. Check the latest studies of Light chain analysis increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

29,547 people reported to have side effects when taking Lortab.
Among them, 18 people (0.06%) have Light chain analysis increased.

Could Lortab cause Light chain analysis increased?

Among these 18 people:

What is the gender of people who have Light chain analysis increased when taking Lortab? *

  • female: 94.44 %
  • male: 5.56 %

What is the age of people who have Light chain analysis increased when taking Lortab? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 94.44 %
  • 50-59: 0.0 %
  • 60+: 5.56 %

What are other drugs people take besides Lortab? *

  1. Zyloprim: 17 people, 94.44%
  2. Percocet: 17 people, 94.44%
  3. Nystatin: 17 people, 94.44%
  4. Ms Contin: 17 people, 94.44%
  5. Miralax: 17 people, 94.44%
  6. Zovirax: 17 people, 94.44%
  7. Lomotil: 17 people, 94.44%
  8. Lipitor: 17 people, 94.44%
  9. Levaquin: 17 people, 94.44%
  10. Lasix: 17 people, 94.44%

What are other side effects people have besides Light chain analysis increased? *

  1. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 17 people, 94.44%
  2. Blood Alkaline Phosphatase Increased: 17 people, 94.44%
  3. Oropharyngeal Pain: 17 people, 94.44%
  4. Oral Pain: 17 people, 94.44%
  5. Oral Herpes (viral infection of mouth): 17 people, 94.44%
  6. Oesophageal Stenosis (narrowing of oesophagus): 17 people, 94.44%
  7. Oesophageal Pain: 17 people, 94.44%
  8. Oesophageal Candidiasis (fungal infection of oesophagus): 17 people, 94.44%
  9. Nausea (feeling of having an urge to vomit): 17 people, 94.44%
  10. Compression Fracture (fracture due to pressure caused by injury): 17 people, 94.44%

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 1 person, 5.56%
  2. Multiple Myeloma (cancer of the plasma cells): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and have Light chain analysis increased?

- Check whether Light chain analysis increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lortab:

Light chain analysis increased treatments and more:

How severe was Light chain analysis increased and when was it recovered:

Expand to all the drugs that have ingredients of acetaminophen; hydrocodone bitartrate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Light chain analysis increased:

Browse all the conditions that are associated with Light chain analysis increased:


How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate (the active ingredients of Lortab) and Lortab (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: